Regencell Bioscience Holdings Limited (NASDAQ:RGC - Get Free Report)'s share price rose 24.2% on Wednesday . The company traded as high as $18.41 and last traded at $16.98. Approximately 1,755,281 shares traded hands during mid-day trading, a decline of 86% from the average daily volume of 12,884,282 shares. The stock had previously closed at $13.67.
Regencell Bioscience Stock Down 2.8%
Institutional Investors Weigh In On Regencell Bioscience
A hedge fund recently bought a new stake in Regencell Bioscience stock. Greenfield Savings Bank acquired a new position in shares of Regencell Bioscience Holdings Limited (NASDAQ:RGC - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 11,000 shares of the company's stock, valued at approximately $187,000. Hedge funds and other institutional investors own 0.13% of the company's stock.
About Regencell Bioscience
(
Get Free Report)
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.
Recommended Stories
Before you consider Regencell Bioscience, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Regencell Bioscience wasn't on the list.
While Regencell Bioscience currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
